Mevion Medical Systems, Inc.

Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u

The median value of super-sized medtech financings hit a high of $100 million in 2015. Five companies closed on venture deals worth $50 million or more, and three of those five raised at least $100 mi

2015 was a truly remarkable year for early-stage venture capital investment in the life science sector. The total amount of money raised in A rounds by life science companies (biopharma, pharma, medte

Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of